Quantcast

Department of Internal Medicine

Amparo C. Villablanca, M.D.

Amparo C. Villablanca

Clinical/Research Interests

Dr. Villablanca's clinical interests focus on heart disease in women, health care outcomes for women, health disparities, gender-based medicine and translational research (soy, natural estrogens and heart disease protection). Her basic research interests include the molecular biology of sex hormone and sex steroid hormone receptor vascular protection and the regulation of atherosclerosis susceptibility. Dr. Villablanca's philosophy of care is woman-centered, and culturally sensitive, with respect for each patient.

Title:

Director, Women’s Cardiovascular Medicine Program
Professor and Lazda Endowed Chair, Women's Cardiovascular Medicine
Associate Director, Women's Center for Health

Specialty:

Cardiovascular Medicine

Center/Program Affiliation:

Heart Center, UC Davis Medical Group, Women's Center for Health

Address:

Lawrence J. Ellison Ambulatory Care Center
4860 Y St., Suite 0200
Sacramento, CA 95817

Phone:

(916) 734-1966

Other Languages:

French, Spanish

Education:

UC Davis School of Medicine
Davis, California
M.D. 1983

UCLA
Los Angeles, California
B.S. 1979

Internships:

UC Davis Medical Center
Sacramento, California
1983-1984

Residency:

UC Davis Medical Center
Sacramento, California
1983-86
Internal Medicine

Fellowships:

UC Davis Medical Center
Sacramento, California
1987-90
Cardiovascular Medicine

Board Certifications:

American Board of Internal Medicine, Cardiovascular Disease, 1993
American Board of Internal Medicine, 1987

Professional Memberships:

American Heart Association (Fellow, Atherosclerosis, Thrombosis and Vascular Biology Council)
Mouse Biology Program (UC Davis)
National Heart Blood and Lung Institute (National Spokeswoman and West Coast Partner)

Select Recent Publications:

Wang-Polagruto, J, AC Villablanca, L Lee, J Polagruto, RA Holt, H Schrader, J Ensunsa, FM Steinberg, H Schmitz and CL Keen. Chronic consumption of flavanol-rich cocoa improves endothelial function and decreases vascular cell adhesion molecule (VCAM-1) in hypercholesterolemic postmenopausal women. J Cardiovascular Pharmacology. (In press)

Benton, J, A Powers, L Eiselein, R Fitch, D Wilson, AC Villablanca and JC Rutledge. Hyperglycemia and loss of ovarian hormones mediate atheroma formation through endothelial layer disruption and increased permeability. Am J Physiol. (In press)

Villablanca, AC, D Lubhan, L Shelby, K Lloyd and S Barthold. Susceptibility to early atherosclerosis in male mice is mediated by estrogen receptor a (ERa). Atherosclerosis, Thrombosis and Vascular Biology, 24:1055-1061 (with journal editorial). Erratum in: Arterioscler Thromb Vasc Biol, 24(6):1055-1061.

Nandur, R, K Kumar and AC Villablanca. Cardiovascular actions of selective estrogen receptor modulators (SERMs) and phytoestrogens. Preventive Cardiology, 7:73-79. Invited review.

Villablanca, AC, KA Lewis and JC Rutledge. Differential regulation of gene expression by ovariectomy in mouse aorta. Physiological Genomics, 12:175-185. [online] http://www.10.1152/physiolgenomics.00040.2002.

Steinberg, FM, NG Guthrie, AC Villablanca, K Kumar and MJ Murray. In healthy post-menopausal women, soy isoflavones have favorable effects on endothelial function, which are independent of lipid and antioxidant effects. Amer J Clinical Nutrition, 78:123-130.

Smith, S and AC Villablanca. The effect of estrogen on inflammatory genes and proteins in atherosclerotic vessels. UC Davis proceedings from the Howard Hughes Medical Institute Summer Honors Advanced Research Program (SHARP) Focused Integrative Research Scholar Training (FIRST).

Villablanca, AC, KA Lewis and JC Rutledge. Time- and dose-dependent differential up-regulation of three genes by 17 b-estradiol in human aortic endothelial cells. J Applied Physiology, 92(3):1064-1073. [online] November 2, 2001, http://www.10.1152/japplphysiol.00374.2001.

Ariyo, AA and Villablanca AC. Estrogens and lipids: Can HRT, designer estrogens and phytoestrogens reduce cardiovascular risk markers after menopause? Postgraduate Medicine, 111(1):23-30. Invited review.

Villablanca, AC. Hormone replacement therapy and cardiovascular risk in women: Where do we stand? Women's Health in Primary Care, 4(2):121-129. Invited review.

Amparo C. Villablanca is currently accepting new patients. To schedule an appointment, please call (916) 734-1966